Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
ON ›
ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%
Trademark search for:
ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-02-05 — Application filed
2018-02-08 — Application filed
2018-02-13 — Application filed
2018-02-14 — Notice of design search code e-mailed
2018-05-18 — Assigned to examiner
2018-05-28 — Final disposition recorded
2018-05-28 — Final disposition recorded
2018-05-28 — Final disposition recorded
2018-11-28 — Office action issued
2018-12-04 — Assigned to lie
2018-12-12 — Correspondence received in law office
2018-12-12 — Teas/email correspondence entered
2018-12-12 — Approved for pub - principal register
2019-01-02 — Notification of notice of publication e-mailed
2019-01-22 — Published for opposition
2019-01-22 — Official gazette publication confirmation e-mailed
2019-03-19 — Noa e-mailed - sou required from applicant
2019-09-19 — Sou extension 1 filed
2019-10-21 — Application abandoned
2019-10-21 — Application abandoned
2019-10-21 — Teas petition to revive received
2019-10-21 — Petition to revive-granted
2019-10-21 — Sou extension received with teas petition
2019-10-21 — Notice of revival - e-mailed
2019-11-08 — Case assigned to intent to use paralegal
2019-11-08 — Sou extension 1 granted
2019-11-09 — Notice of approval of extension request e-mailed
2020-03-12 — Sou teas extension received
2020-03-12 — Sou extension 2 filed
2020-03-12 — Sou extension 2 granted
2020-03-14 — Notice of approval of extension request e-mailed
2020-09-11 — Sou teas extension received
2020-09-11 — Sou extension 3 filed
2020-09-11 — Sou extension 3 granted
2020-09-15 — Notice of approval of extension request e-mailed
2021-04-19 — Application abandoned
2021-04-19 — Application abandoned
2021-04-19 — Final status recorded
Owner Information
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc.
Correspondent
Melissa W. Woo-Allen WOO ALLEN LAW LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
